These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26623099)

  • 1. Pharmacological treatment response according to the severity of symptoms in patients with chronic obstructive pulmonary disease.
    Lee JS; Seo JB; Lee SM; Park TS; Lee SW; Oh YM; Lee JH; Kim EK; Kim TH; Park JH; Sheen SS; Lim SY; Jung I; Lee SD
    J Thorac Dis; 2015 Oct; 7(10):1765-73. PubMed ID: 26623099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses.
    Kim S; Oh J; Kim YI; Ban HJ; Kwon YS; Oh IJ; Kim KS; Kim YC; Lim SC
    BMC Pulm Med; 2013 Jun; 13():35. PubMed ID: 23731868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study.
    Zhou Z; Zhou A; Peng Y; Duan J; Zeng Y; Zhao Y; Cheng W; Chen P
    Respiration; 2020; 99(7):606-616. PubMed ID: 32659763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD.
    Rhee CK; Kim JW; Hwang YI; Lee JH; Jung KS; Lee MG; Yoo KH; Lee SH; Shin KC; Yoon HK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1623-31. PubMed ID: 26316736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) dyspnea scores for evaluation of clinical symptoms, comorbidities and medical resources utilization in COPD patients.
    Cheng SL; Lin CH; Wang CC; Chan MC; Hsu JY; Hang LW; Perng DW; Yu CJ; Wang HC;
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):429-435. PubMed ID: 30150099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GOLD Classification of COPD: Discordance in Criteria for Symptoms and Exacerbation Risk Assessment.
    Mittal R; Chhabra SK
    COPD; 2017 Feb; 14(1):1-6. PubMed ID: 27723367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in Assignment of the COPD Patients into a GOLD Group According to Symptoms Severity.
    Moya-Álvarez V; Quevedo-Marín JL; Ji Z; Navarro-Jiménez C; Jiménez-García R; López-de-Andrés A; Pérez-Trullén A; de Miguel-Díez J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1987-1995. PubMed ID: 32848383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the modified Medical Research Council dyspnea scale with airway structure assessed by three-dimensional CT in patients with chronic obstructive pulmonary disease.
    Yasui H; Inui N; Karayama M; Mori K; Hozumi H; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
    Respir Med; 2019 Jan; 146():76-80. PubMed ID: 30665522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified Medical Research Council Dyspnea Scale in GOLD Classification Better Reflects Physical Activities of Daily Living.
    Munari AB; Gulart AA; Dos Santos K; Venâncio RS; Karloh M; Mayer AF
    Respir Care; 2018 Jan; 63(1):77-85. PubMed ID: 28874609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study.
    Oca MM; Varela MVL; Menezes AMB; Wehrmeister FC; Ramirez L; Miravitlles M
    J Bras Pneumol; 2021; 47(5):e20210156. PubMed ID: 34787288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Modified Medical Research Council Dyspnea Scale for Predicting Hospitalization and Exacerbation in Japanese Patients with Chronic Obstructive Pulmonary Disease.
    Natori H; Kawayama T; Suetomo M; Kinoshita T; Matsuoka M; Matsunaga K; Okamoto M; Hoshino T
    Intern Med; 2016; 55(1):15-24. PubMed ID: 26726080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic obstructive pulmonary disease assessment test: usefulness for monitoring recovery and predicting poor course of disease after exacerbations.
    Pulido Herrero E; García Gutiérrez S; Antón Ladislao A; Piñera Salmerón P; Martín Corral MJ; Gorordo Unzueta MI; Lopetegui Eraso P; García Lamberechts EJ; Quintana López JM
    Emergencias; 2019 Feb; 31(1):21-26. PubMed ID: 30656869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
    Casanova C; Marin JM; Martinez-Gonzalez C; de Lucas-Ramos P; Mir-Viladrich I; Cosio B; Peces-Barba G; Solanes-García I; Agüero R; Feu-Collado N; Calle-Rubio M; Alfageme I; de Diego-Damia A; Irigaray R; Marín M; Balcells E; Llunell A; Galdiz JB; Golpe R; Lacarcel C; Cabrera C; Marin A; Soriano JB; Lopez-Campos JL; Soler-Cataluña JJ; de-Torres JP;
    Chest; 2015 Jul; 148(1):159-168. PubMed ID: 25612228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of comorbid heart disease on dyspnea and health status in patients with COPD - a cohort study.
    Giezeman M; Hasselgren M; Lisspers K; Ställberg B; Montgomery S; Janson C; Sundh J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3857-3865. PubMed ID: 30568437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparisons of health status scores with MRC grades in COPD: implications for the GOLD 2011 classification.
    Jones PW; Adamek L; Nadeau G; Banik N
    Eur Respir J; 2013 Sep; 42(3):647-54. PubMed ID: 23258783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of symptom and risk assessment methods among patients with chronic obstructive pulmonary disease.
    Zhang R; Tan X; He Q; Chen Q; Gai J; Wei J; Wang Y
    Chin Med J (Engl); 2014; 127(14):2594-8. PubMed ID: 25043073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients.
    Zhou QT; Mei JJ; He B; Huang SG; Shi Y; Wen FQ; Zhao MW
    Chin Med J (Engl); 2013 Jan; 126(1):11-5. PubMed ID: 23286470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COPD assessment test and the modified Medical Research Council scale are not equivalent when related to the maximal exercise capacity in COPD patients.
    Pisi R; Aiello M; Calzetta L; Frizzelli A; Tzani P; Bertorelli G; Chetta A
    Pulmonology; 2023; 29(3):194-199. PubMed ID: 34233862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.